Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Infinity Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (73)	8/28/2006 4:58:46 PM
From: Mike McFarland	Read Replies (3) \| Respond to of 210

(Nereus, Kosan) Natural product synthesis (polyketides I think) I don't want to go into chemistry, I am far too ignorant about that to do any more than speculate that they are a goot fit. Good grief, a 70m deal and the stock only closes up 9%?! What a lot of crap is Wall Street. In early 2000 the shares would have doubled, no tripled. I guess Infinity doesn't need dpi anymore-- maybe the powers that be have to build that into the shareprice now, or somethin'. Nobody gets my shares, but as I said, two steps forward, one back. The only way I am going to play this is hold it--til they're equal to 10% of a Biogen. Nice.